Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Trypanosoma cruzi | farnesyl pyrophosphate synthase | Starlite/ChEMBL | References |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | > 10 uM | Antiparasitic activity against Toxoplasma gondii tachyzoite expressing red fluorescence protein assessed as growth inhibition by fluorescence plate reader | ChEMBL. | 23318904 |
ED50 (functional) | > 20 uM | Antiparasitic activity against Trypanosoma cruzi amastigotes infected in gamma-irradiated vero cells assessed as growth inhibition measured after 3 days by fluorescence assay | ChEMBL. | 23318904 |
IC50 (binding) | > 10 uM | Inhibition of Trypanosoma cruzi farnesyl diphosphate synthase assessed as incorporation of [4-14C]IPP measured at 37 degC | ChEMBL. | 23318904 |
IC50 (binding) | > 10 uM | Inhibition of Toxoplasma gondii farnesyl diphosphate synthase assessed as incorporation of [4-14C]IPP measured at 37 degC | ChEMBL. | 23318904 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.